These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10681718)

  • 21. In vitro drug resistance in acute myeloid and chronic B-lymphocytic leukaemic blasts and in normal blood and marrow populations.
    Baines P; Limaye M; Hoy T; Padua RA; Whittaker J; al-Sabah A; Burnett A
    Leuk Res; 1994 Sep; 18(9):683-91. PubMed ID: 7934144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute erythroid neoplastic proliferations. A biological study based on 62 patients.
    Domingo-Claros A; Larriba I; Rozman M; Irriguible D; Vallespí T; Aventin A; Ayats R; Millá F; Solé F; Florensa L; Gallart M; Tuset E; Lopez C; Woessner S
    Haematologica; 2002 Feb; 87(2):148-53. PubMed ID: 11836165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the relationship between Scl transcription factor complex protein expression patterns and the effects of LiCl on ATRA-induced differentiation in blast cells from patients with acute myeloid leukemia.
    Rice AM; Holtz KM; Karp J; Rollins S; Sartorelli AC
    Leuk Res; 2004 Nov; 28(11):1227-37. PubMed ID: 15380350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
    Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
    Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia.
    Pearson L; Leith CP; Duncan MH; Chen IM; McConnell T; Trinkaus K; Foucar K; Willman CL
    Leukemia; 1996 Aug; 10(8):1274-82. PubMed ID: 8709631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M; Kusenda J; Babusikova O
    Neoplasma; 2005; 52(3):211-8. PubMed ID: 15875082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Zühlsdorf M; Rolf C; Reuter C; Kewer U; Uhrmeister C; Wörmann B; Büchner T
    Leukemia; 1992 Dec; 6(12):1273-80. PubMed ID: 1453772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunophenotyping is an independent factor for risk stratification in AML.
    Repp R; Schaekel U; Helm G; Thiede C; Soucek S; Pascheberg U; Wandt H; Aulitzky W; Bodenstein H; Sonnen R; Link H; Ehninger G; Gramatzki M;
    Cytometry B Clin Cytom; 2003 May; 53(1):11-9. PubMed ID: 12717686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of MOST-1 mRNA in bone marrow mononuclear cells from patients with acute lymphoblastic leukemia].
    Gao J; Yuan LX; Sun L; Li XX; Liao QK
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):638-40. PubMed ID: 15460406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.
    Sumi M; Tauchi T; Sashida G; Nakajima A; Gotoh A; Shin-Ya K; Ohyashiki JH; Ohyashiki K
    Int J Oncol; 2004 Jun; 24(6):1481-7. PubMed ID: 15138591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia.
    Xie XY; Robb D; Chow S; Hedley DW
    Leukemia; 1995 Nov; 9(11):1882-7. PubMed ID: 7475279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: a Southwest Oncology Group Study.
    Bickers J; Benjamin R; Wilson H; Eyre H; Hewlett J; McCredie K
    Cancer Treat Rep; 1981; 65(5-6):427-30. PubMed ID: 6940659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytogenetic study of cell sub-populations in human leukemias (AML, CML) sorted by flow cytometry].
    Lacombe F; Belloc F; Bernard P; Dachary D; Boisseau MR
    Pathol Biol (Paris); 1988 Jan; 36(1):42-5. PubMed ID: 3283670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo uptake of daunorubicin by acute myeloid leukemia (AML) cells measured by flow cytometry.
    Kokenberg E; Sonneveld P; Delwel R; Sizoo W; Hagenbeek A; Löwenberg B
    Leukemia; 1988 Aug; 2(8):511-7. PubMed ID: 3166077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immobilized forms of daunorubicin in patients with acute leukemia].
    Isaev VG; Garmaeva TTs; Skorokhod AA; Parovichnikova EN; Tiurina NG; Kucher RA; Vitvitskiĭ VM; Ataullakhanov FI; Savchenko VG
    Ter Arkh; 1999; 71(10):32-7. PubMed ID: 10612171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.
    Wulf GG; Wang RY; Kuehnle I; Weidner D; Marini F; Brenner MK; Andreeff M; Goodell MA
    Blood; 2001 Aug; 98(4):1166-73. PubMed ID: 11493466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-resistance to rhodamine 123 in Adriamycin- and daunorubicin-resistant Friend leukemia cell variants.
    Tapiero H; Munck JN; Fourcade A; Lampidis TJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5544-9. PubMed ID: 6498816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.